Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,148.42
(
0.00%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: urche post# 129277

Monday, 10/24/2011 9:38:12 PM

Monday, October 24, 2011 9:38:12 PM

Post# of 257580

As if to preempt the Xarelto sNDA submission, Public Citizen is campaigning to stave off approval on grounds the ROCKET-AF study was seriously flawed. Although I have heard many of these criticisms, I wonder what is the motive or agenda of Public Citizen? Are they interested in costs, wanting to avoid expensive new drugs with marginal advantages?

Public Citizen does not corporations to make money by selling drugs. It’s really that simple.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today